Lithium Carbonate 450 mg / 1 Tablet 30 Tablet, Extended Release

Reference details for licensed healthcare facility review and verification.

NDC 1143063-0901-30
Product NDC43063-0901
Generic Drug NameLithium Carbonate
Brand NameLithium Carbonate
ManufacturerPD-Rx Pharmaceuticals, Inc.
Strength450 mg / 1
Dosage FormTablet
Drug TypeOral
Package Quantity30 Tablet, Extended Release
Package Description30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (43063-901-30)
Active IngredientsLithium Carbonate
Marketing CategoryANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

NDC snapshot

Lithium Carbonate 450 mg / 1 Tablet is tracked under NDC 43063-0901-30 and rolls up into product family 43063-0901. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

  • Package configuration: 30 Tablet, Extended Release.
  • Manufacturer: PD-Rx Pharmaceuticals, Inc..
  • Dosage form: Tablet.
  • Family size: 2 indexed presentations.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Lithium Carbonate 450 mg / 1 Tablet 30 Tablet, Extended Release, NDC 43063-0901-30, is a PD-Rx Pharmaceuticals, Inc. 450 mg / 1 tablet presentation packaged as 30 Tablet, Extended Release.

NDC search formats

  • Canonical NDC 11: 43063-0901-30
  • Digits-only NDC 11: 43063090130
  • Possible 10-digit display format: 43063-901-30 (4306390130)

Helpful product links